UPDATE 2-Jazz Pharma to buy Italy's Gentium for $1 bln

Ireland-based Jazz Pharmaceuticals Plc said it would buy Italian biotech company Gentium S.p.A. for about $1 billion to get access to its lead product candidate, Defitelio, a drug used for the treatment of a rare liver condition.

http://www.reuters.com/article/2013/12/19/gentium-offer-jazz-idUSL3N0JY3YQ20131219?type=companyNews&feedType=RSS&feedName=companyNews